Robert D. Hawkins - Researcher Profile

Publications

2 shown

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini , Elizabeth R. Plimack , V.P. Stus +24 more

Among patients with previously untreated advanced renal-cell carcinoma, treatment with pembrolizumab plus axitinib resulted in significantly longer overall survival and progress...

2019 New England Journal of Medicine 3200 citations

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,603
Institution: Cancer Research Horizons

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9089-8544

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.